Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist
1998767 citationsBarry Bresnihan, Mark Cobby et al.Arthritis & Rheumatismprofile →
Citations per year, relative to Z Domljan Z Domljan (= 1×)
peers
Predrag Musikic
Countries citing papers authored by Z Domljan
Since
Specialization
Citations
This map shows the geographic impact of Z Domljan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Z Domljan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Z Domljan more than expected).
This network shows the impact of papers produced by Z Domljan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Z Domljan. The network helps show where Z Domljan may publish in the future.
Co-authorship network of co-authors of Z Domljan
This figure shows the co-authorship network connecting the top 25 collaborators of Z Domljan.
A scholar is included among the top collaborators of Z Domljan based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Z Domljan. Z Domljan is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
All Works
18 of 18 papers shown
1.
Bresnihan, Barry, Mark Cobby, Michael Doherty, et al.. (1999). Reply. Arthritis & Rheumatism. 42(8). 1782–1782.1 indexed citations
Bresnihan, Barry, Mark Cobby, Michael Doherty, et al.. (1998). Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist. Arthritis & Rheumatism. 41(12). 2196–2204.767 indexed citations breakdown →
Domljan, Z, et al.. (1987). Renal changes in patients with rheumatoid arthritis treated with sodium thiomalate and D-penicillamine.. PubMed. 41(5). 363–72.1 indexed citations
10.
Domljan, Z, et al.. (1986). [Radial epicondylitis. Prospective comparative study of 3 treatment methods].. PubMed. 33(5-6). 126–9.2 indexed citations
Domljan, Z, et al.. (1984). The value of early and late 99mTc-methylene diphosphonate scintigrams of hands in patients with rheumatoid arthritis and other inflammatory rheumatic diseases.. PubMed. 43(4). 167–70.5 indexed citations
14.
Domljan, Z, et al.. (1976). [Demonstration of popliteal cysts using intra-articular administration of isotopes (proceedings)].. PubMed. 35 Suppl 4. suppl 215–20.1 indexed citations
Domljan, Z. (1969). [Canalicular pain syndromes in the upper extremities].. PubMed. 91(9). 959–70.1 indexed citations
17.
Domljan, Z, et al.. (1969). Clinical observations with mydocalm and rheumicalm in various rheumatic diseases. A preliminary report.. PubMed. 17(3). 114–9.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.